ATE81456T1 - Dl-5-((2-benzyl-3,4-dihydro-2h-benzopyran-6yl)methyl>thiazolidin-2,4-dion als antiatherosklerosemittel. - Google Patents

Dl-5-((2-benzyl-3,4-dihydro-2h-benzopyran-6yl)methyl>thiazolidin-2,4-dion als antiatherosklerosemittel.

Info

Publication number
ATE81456T1
ATE81456T1 AT88311378T AT88311378T ATE81456T1 AT E81456 T1 ATE81456 T1 AT E81456T1 AT 88311378 T AT88311378 T AT 88311378T AT 88311378 T AT88311378 T AT 88311378T AT E81456 T1 ATE81456 T1 AT E81456T1
Authority
AT
Austria
Prior art keywords
dione
benzopyran
dihydro
benzyl
methyl
Prior art date
Application number
AT88311378T
Other languages
German (de)
English (en)
Inventor
Michael Norman Krupp
Archie Calhoum Swindell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE81456T1 publication Critical patent/ATE81456T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT88311378T 1987-12-02 1988-12-01 Dl-5-((2-benzyl-3,4-dihydro-2h-benzopyran-6yl)methyl>thiazolidin-2,4-dion als antiatherosklerosemittel. ATE81456T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/127,858 US4798835A (en) 1987-12-02 1987-12-02 dl-5-[(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl]thiazolidine-2,4-dione as an anti-atherosclerosis agent
EP88311378A EP0319288B1 (en) 1987-12-02 1988-12-01 dl-5-[(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl]thiazolidine-2,4-dione as an anti-atherosclerosis agent

Publications (1)

Publication Number Publication Date
ATE81456T1 true ATE81456T1 (de) 1992-10-15

Family

ID=22432331

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88311378T ATE81456T1 (de) 1987-12-02 1988-12-01 Dl-5-((2-benzyl-3,4-dihydro-2h-benzopyran-6yl)methyl>thiazolidin-2,4-dion als antiatherosklerosemittel.

Country Status (16)

Country Link
US (1) US4798835A (pt)
EP (1) EP0319288B1 (pt)
JP (1) JPH01186883A (pt)
KR (1) KR900006993B1 (pt)
AT (1) ATE81456T1 (pt)
AU (1) AU604176B2 (pt)
CA (1) CA1313139C (pt)
DE (1) DE3875324T2 (pt)
DK (1) DK670988A (pt)
HU (1) HU204433B (pt)
IE (1) IE883600L (pt)
IL (1) IL88513A (pt)
MY (1) MY103498A (pt)
PH (1) PH24873A (pt)
PT (1) PT89123B (pt)
ZA (1) ZA888968B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053420A (en) * 1989-10-13 1991-10-01 Pershadsingh Harrihar A Thiazolidine derivatives for the treatment of hypertension
EP0494405B2 (en) * 1991-01-10 2000-04-19 Transcend Therapeutics, Inc. Use of L-2-oxo thiazolidine-4-carboxylate for the treatment of pulmonary diseases
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5866595A (en) * 1991-09-26 1999-02-02 The Regents Of The University Of California Calcium antagonists for treatment of vascular restenosis
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5306724A (en) * 1992-08-17 1994-04-26 Clintec Nutrition Company Method for preventing and treating atherosclerosis
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
GB9611947D0 (en) * 1996-06-07 1996-08-07 Glaxo Group Ltd Medicaments

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS58118577A (ja) * 1982-01-07 1983-07-14 Takeda Chem Ind Ltd チアゾリジン誘導体
US4617312A (en) * 1983-01-17 1986-10-14 Pfizer Inc. Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinediones
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
WO1986007056A1 (en) * 1985-05-21 1986-12-04 Pfizer Inc. Hypoglycemic thiazolidinediones
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物

Also Published As

Publication number Publication date
JPH0460582B2 (pt) 1992-09-28
AU2647188A (en) 1989-06-08
JPH01186883A (ja) 1989-07-26
AU604176B2 (en) 1990-12-06
ZA888968B (en) 1990-07-25
EP0319288A2 (en) 1989-06-07
IE883600L (en) 1989-06-02
MY103498A (en) 1993-06-30
PT89123B (pt) 1993-09-30
PH24873A (en) 1990-12-26
HUT54045A (en) 1991-01-28
DK670988A (da) 1989-07-24
PT89123A (pt) 1989-12-29
IL88513A (en) 1994-04-12
IL88513A0 (en) 1989-06-30
DE3875324T2 (de) 1993-02-25
DK670988D0 (da) 1988-12-01
US4798835A (en) 1989-01-17
DE3875324D1 (de) 1992-11-19
KR890009922A (ko) 1989-08-04
KR900006993B1 (ko) 1990-09-25
EP0319288B1 (en) 1992-10-14
HU204433B (en) 1992-01-28
EP0319288A3 (en) 1990-12-27
CA1313139C (en) 1993-01-26

Similar Documents

Publication Publication Date Title
DK233586D0 (da) 5-substituerede 1,3-thiazolidon-2,4-dion-forbindelser og farmaceutiske praeparater indeholdende disse
ATE81456T1 (de) Dl-5-((2-benzyl-3,4-dihydro-2h-benzopyran-6yl)methyl>thiazolidin-2,4-dion als antiatherosklerosemittel.
DK165982C (da) Imidazolylguanidinderivater og laegemidler, der indeholder disse forbindelser
KR910004191A (ko) 신질환치료제
DK397383A (da) 2-nitro-1,1-ethendiaminer, fremgangsmaader til fremstilling deraf samt deres anvendelse som laegemidler
DZ2430A1 (fr) Procédé pour la préparation de dérivés de thiazolidinedione substitués.
KR900009647A (ko) 아데노신 유도체, 그들의 제법 및 사용방법
DK520787D0 (da) Terapeutisk middel indeholdende propentofyllin eller derivater deraf til brug ved behandling af peptisk ulcus
NO166400C (no) Anodning ved delvis nedsenkbar plattform.
EP0292352A3 (fr) Nouveaux dérivés macrolides, leur procédé de préparation et les compositions pharmaceutiques les contenant
DE69018099D1 (de) Polyamin-Derivate als antineoplastische Mittel.
ATE175673T1 (de) Alkylidenanaloge von 1'-aminospiro-(isochinolin- 4(1h), 3'-pyrrolidin>-1,2',3,5'(2h)-tetronen, verwendbar als aldose reduktase-inhibitoren in vivo
ATE45574T1 (de) Aldosereduktasehemmende 5-(2alkoxyphenyl)thiazolidinedione.
HUP0002727A2 (hu) Eljárás fibrinogén csökkentésére benzotiofénszármazékok felhasználásával
ATE81005T1 (de) Ponalrestat enthaltendes hyperurikaemie-mittel.
DK69889A (da) 2-substituerede carbonylimidazol(4,5-c)-quinoliner
ATE81983T1 (de) Absorptionsverbesserer fuer proteine.
DK175787A (da) Stabile, injicerbare antiemetiske praeparater
FI892577A0 (fi) Vattenhaltig framkallarkomposition foer med loesningsmedel framkallbara fotoresistbelaeggningar.
IL83214A (en) 5-substituted thiazolidine-2,4-diones as hyperglycemic agents
KR890011593A (ko) 쇼크 치료에 사용하기 위한 2-(페닐아미노)이미디졸린-(2)의 용도

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee